Skip to content

Effect of Yinqiao Qingyan Granules in treating the acute bronchitis infected by respiratory syncytial virus in children

Effect of Yinqiao Qingyan Granules in treating the acute bronchitis infected by respiratory syncytial virus in children

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003301
Enrollment
Unknown
Registered
2020-05-12
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute bronchitis infected by respiratory syncytial virus

Interventions

Sponsors

Guangdong Secondary Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: According to the guideline on evaluation of Chinese materia medica research for treatment of acute 1. Patients who meet the diagnostic criteria of Western medicine and traditional Chinese medicine. 2. Patients aged 1-14. 3. Patients with acute course of disease and onset time not more than 72 hours. 4. Informed consent, legal guardian or child is willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe bronchitis whose body temperature was over 38.5 degrees C or pneumonia 24 hours before admission. 2. Patients with bacterial infection, influenza, asthma and other respiratory diseases or infectious diseases. 3. Patients with severe heart, liver, kidney, digestive and hematopoietic diseases. 4. Patients with malnutrition, immune deficiency or genetic diseases. 5. People who are allergic to drugs.

Design outcomes

Primary

MeasureTime frame
Cough symptom score;Symptoms score of traditional Chinese medicine;Total effective rate;

Secondary

MeasureTime frame
Serum concentrations of IL-10;Serum concentrations of IL-6;Serum concentrations of MIF;Serum concentrations of TNF-a;

Countries

China

Contacts

Public ContactJiahui Xu

Guangdong Secondary Hospital of Traditional Chinese Medicine

ceoiron@vip.qq.com+86 13719286738

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026